SOTERA HEALTH COMPANY (SHC) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.86M; Additional Paid in CapitalUSD $1.27B; Treasury Stock, Common, ValueUSD (m).
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.86M; Additional Paid in CapitalUSD $1.26B; Treasury Stock, Common, ValueUSD (m).
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.86M; Additional Paid in CapitalUSD $1.26B; Treasury Stock, Common, ValueUSD (m).
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.86M; Additional Paid in CapitalUSD $1.26B; Treasury Stock, Common, ValueUSD (m).
SOTERA HEALTH COMPANY Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $2.86M | $1.27B | (m) | $9.29M | $-143.46M | $-451.86M | $665.65M | 675.00K | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $2.86M | $1.26B | (m) | $12.10M | $-125.94M | $-505.50M | $622.50M | 881.00K | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $2.86M | $1.26B | (m) | $17.01M | $-109.84M | $-532.09M | $606.03M | 1.67M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $2.86M | $1.26B | (m) | $18.66M | $-125.51M | $-566.94M | $550.47M | 1.95M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $2.86M | $1.25B | (m) | $19.04M | $-108.29M | $-615.34M | $511.28M | 1.99M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $2.86M | $1.24B | (m) | $20.86M | $-189.45M | $-623.30M | $414.09M | 2.18M | 3 month · $270.00K | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $2.86M | $1.24B | $23.43M | $23.43M | $-208.25M | $-610.04M | $404.91M | 2.57M | 12 month · $10.02M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $2.86M | $1.24B | $24.61M | (m) | $-124.62M | $-622.37M | $470.16M | 2.80M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $2.86M | $1.23B | $24.76M | (m) | $-145.40M | $-639.36M | $422.76M | 2.82M | 3 month · $3.67M 6 month · $7.34M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $2.86M | $1.22B | (m) | $26.04M | $-119.86M | $-648.12M | $429.39M | 2.97M | 3 month · $3.67M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $2.86M | $1.22B | $27.18M | $27.18M | $-92.68M | $-654.44M | $443.73M | 3.21M | 12 month · $22.34M | $443.73M | (m) | (m) |
| 2023-09-30 | $0.00 | $2.86M | $1.21B | (m) | $28.47M | $-114.14M | $-693.12M | $377.47M | 3.41M | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $2.86M | $1.20B | $28.70M | (m) | $-79.30M | $-679.46M | $418.37M | 3.49M | 3 month · $6.99M 6 month · $13.89M | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $2.86M | $1.20B | (m) | $29.42M | $-104.70M | $-702.97M | $361.12M | (m) | 3 month · $6.80M | (m) | (m) | 3.52M |
| 2022-12-31 | $0.00 | $2.86M | $1.19B | $29.77M | $29.77M | $-106.65M | $-705.82M | $350.24M | 3.62M | 12 month · $13.00K | $350.24M | (m) | 3.62M |
| 2022-09-30 | $0.00 | $2.86M | $1.19B | (m) | $32.65M | $-164.00M | $-386.10M | $606.73M | (m) | (m) | $606.73M | 3 month · $4.63M 9 month · $14.92M | 3.92M |
| 2022-06-30 | $0.00 | $2.86M | $1.18B | (m) | $32.65M | $-105.01M | $-411.19M | $636.00M | (m) | 3 month · $2.00K 6 month · $4.00K | $636.00M | 3 month · $5.78M 6 month · $10.29M | 3.13M |
| 2022-03-31 | $0.00 | $2.86M | $1.18B | (m) | $33.54M | $-62.69M | $-441.61M | $642.13M | (m) | (m) | $642.13M | 3 month · $4.51M | 3.11M |
| 2021-12-31 | $0.00 | $2.86M | $1.17B | (m) | $33.55M | $-83.57M | $-472.25M | $586.10M | (m) | 12 month · $-1.04M | $586.10M | (m) | 3.05M |
| 2021-09-30 | $0.00 | $2.86M | $1.17B | (m) | $34.00M | $-105.95M | $-508.24M | $525.77M | (m) | (m) | $525.77M | 3 month · $3.54M 9 month · $9.38M | 3.12M |
| 2021-06-30 | $0.00 | $2.86M | $1.17B | (m) | $34.00M | $-77.47M | $-535.69M | $523.27M | (m) | (m) | $523.27M | 3 month · $2.41M 6 month · $5.85M | 3.12M |
| 2021-03-31 | $0.00 | $2.86M | $1.17B | (m) | $34.00M | $-97.16M | $-578.29M | $463.26M | (m) | (m) | $465.74M | 3 month · $3.44M | 3.09M |
| 2020-12-31 | $0.00 | $2.86M | $1.17B | (m) | $34.00M | $-93.84M | $-589.13M | $452.30M | (m) | (m) | $454.57M | (m) | 3.05M |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-662.00M | 3 month · $901.00K 9 month · $4.02M | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-682.05M | 3 month · $1.39M 6 month · $3.12M | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-715.63M | 3 month · $1.73M | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-641.13M | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $45.49M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |